Please help will mark brainliest Why is the melting of ice a physical change?
A.
It changes the chemical composition of water.
B.
It does not change the chemical composition of water.
C.
It creates new chemical bonds.
D.
It forms new products.
E.
It is an irreversible change that forms new products.

During physical science, ms. greene challenged her students to produce an energy transformation. james and jill wrapped a 4-inch nail with a coil of fifty turns of wire. they connected one end of the coil to one terminal of a knife switch. they connected the other terminal of the knife switch to the battery. finally, they connected the end of the coil to the other terminal of the battery. james held the tip of a 1-inch nail near the flat end of the 4-inch nail. jill closed the knife switch quickly and then opened it. the 1-inch nail was pulled toward the 4-inch nail. what is the best explanation of why the nail moved? a) electrical energy was converted to mechanical energy in the 1-inch nail. b) the 4-inch nail became an electromagnet and the magnetic force attracted the 1-inch nail. c) the electric current in the 4-inch nail was converted to mechanical energy in the 1-inch nail. d) the 4-inch nail had a positive charge and the 1-inch nail had a negative charge. opposites attracted.

The x-coordinate of a particle in curvilinear motion is given by x = 3.1t3 - 4.9t where x is in feet and t is in seconds. the y-component of acceleration in feet per second squared is given by ay = 2.3t. if the particle has y-components y = 0 and vy = 5.0 ft/sec when t = 0, find the magnitudes of the velocity v and acceleration a when t = 1.8 sec. sketch the path for the first 1.8 seconds of motion, and show the velocity and acceleration vectors for t = 1.8 sec. answers: v = ft/sec a = ft/sec2

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.